These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22304)

  • 1. H2-Histamine receptor blocking agents in the Zollinger-Ellison syndrome. Experience in seven cases and implications for long-term therapy.
    McCarthy DM; Olinger EJ; May RJ; Long BW; Gardner JD
    Ann Intern Med; 1977 Dec; 87(6):668-75. PubMed ID: 22304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of histamine H2-receptor antagonist therapy in Zollinger-Ellison syndrome.
    Stabile BE; Ippoliti AF; Walsh JH; Passaro E
    Am J Surg; 1983 Jan; 145(1):17-23. PubMed ID: 6129812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metiamide in the Zollinger-Ellison syndrome.
    Blair EL; Grund ER; Miller IT; Redd JD; Sanders DJ; Thompson MH; Venables CW
    Am J Dig Dis; 1975 Dec; 20(12):1123-30. PubMed ID: 1106187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.
    Lamers CB; Festen HP; van Tongeren JH
    Am J Gastroenterol; 1978 Sep; 70(3):286-91. PubMed ID: 717379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of peptic ulcer in the Zollinger-Ellison syndrome with histamine H2-receptor antagonists (author's transl)].
    Hausamen TU; Fritsch WP; Scholten T; Jungblut R; Strohmeyer G
    Dtsch Med Wochenschr; 1977 Nov; 102(47):1709-12. PubMed ID: 21785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of patients with Zollinger-Ellison syndrome with histamine H2 receptor antagonists].
    Lamers CB
    Tijdschr Gastroenterol; 1977; 20(6):385-93. PubMed ID: 614726
    [No Abstract]   [Full Text] [Related]  

  • 7. H2 receptor antagonists.
    Siepler JK; Campagna KD; Donahue PE; Bombeck CT
    Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Zollinger-Ellison syndrome treated medically by an inhibitor of H2 histamine receptors].
    Bonfils S; Bernier JJ; Mignon M; Hautefeuille P; Corbic M; Marteau J
    Nouv Presse Med; 1975 Oct; 4(33):2377-81. PubMed ID: 653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of a histamine H2-receptor antagonist in the management of patients with the Zollinger-Ellison syndrome.
    Richardson CT; Walsh JH
    N Engl J Med; 1976 Jan; 294(3):133-5. PubMed ID: 616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of H2 antagonists in Zollinger-Ellison syndrome].
    Dammann HG; Walter TA; Müller P; Simon B
    Clin Ter; 1984 Dec; 111(5):393-400. PubMed ID: 6151434
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
    Delchier JC; Soule JC; Mignon M; Goldfain D; Cortot A; Travers B; Isal JP; Bader JP
    Dig Dis Sci; 1986 Jul; 31(7):693-9. PubMed ID: 2873001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H2-receptor antagonists and gastric acid secretion -- a progress report.
    Black JW
    Klin Wochenschr; 1976 Oct; 54(19):911-4. PubMed ID: 10467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2-receptor antagonists in perspective.
    Malagelada JR; Cortot A
    Mayo Clin Proc; 1978 Mar; 53(3):184-90. PubMed ID: 24155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of peptic ulcer with histamine H2 receptor antagonists].
    Domschke W; Domschke S; Demling L
    Fortschr Med; 1977 Aug; 95(31):1899-902. PubMed ID: 19347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Histamine H-2 receptor antagonists and medical treatment of Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Kloeti G
    Sem Hop; 1978 Mar; 54(5-8):309-12. PubMed ID: 29338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with H2 receptor antagonists. Zollinger-Ellison Syndrome.
    Siepler JK; Donahue P; Campagna K; Bombeck CT
    IMJ Ill Med J; 1978 Apr; 153(4):283-7. PubMed ID: 25249
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma-secretin in management of cimetidine therapy for Zollinger-Ellison syndrome.
    Straus E; Greenstein RJ; Yalow RS
    Lancet; 1978 Jul; 2(8080):73-5. PubMed ID: 78299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of acid suppressants in patients with Zollinger-Ellison syndrome.
    Maton PN
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():25-35. PubMed ID: 1679671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of combined anti-secretory treatment (cimétidine and pirenzepin) in Zollinger-Ellison syndrome].
    Bonfils S; Mignon M; Danne O; Maria J
    Nouv Presse Med; 1977 Nov; 6(38):3544-5. PubMed ID: 23518
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
    Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
    Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.